Design, synthesis, and characterization of guanidine derivative with broad-spectrum antimicrobial and antidiabetic inhibitory activities: a comprehensive spectroscopic and computational study | Synapse
April 10, 2026
Design, synthesis, and characterization of guanidine derivative with broad-spectrum antimicrobial and antidiabetic inhibitory activities: a comprehensive spectroscopic and computational study
Puntos clave
The study aims to design and characterize a guanidine derivative with antimicrobial and antidiabetic properties.
Synthesis of a novel guanidine derivative
Spectroscopic characterization to assess chemical properties
Computational analysis to predict pharmacokinetics
In vitro testing for antimicrobial activity and α-amylase inhibition
The guanidine derivative exhibits broad-spectrum antimicrobial activity.
Significant inhibition of α-amylase activity is observed.
Optimization is recommended for improved efficacy and pharmacokinetics.
Resumen
GHC shows broad-spectrum antimicrobial activity and measurable α-amylase inhibition, warranting further optimization to improve efficacy and pharmacokinetics.